ASCENDIS PHARMA A S's ticker is and the CUSIP is 04351P901. A total of 4 filers reported holding ASCENDIS PHARMA A S in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,095 | -19.2% | 11,700 | -23.0% | 0.00% | 0.0% |
| Q2 2023 | $1,356 | -78.9% | 15,200 | -74.7% | 0.00% | -83.3% |
| Q1 2023 | $6,433 | +432.1% | 60,000 | +506.1% | 0.01% | +500.0% |
| Q4 2022 | $1,209 | -99.9% | 9,900 | -23.3% | 0.00% | -50.0% |
| Q3 2022 | $1,332,000 | +1.7% | 12,900 | -8.5% | 0.00% | +100.0% |
| Q2 2022 | $1,310,000 | -42.2% | 14,100 | -26.9% | 0.00% | -50.0% |
| Q1 2022 | $2,265,000 | +3280.6% | 19,300 | +3760.0% | 0.00% | – |
| Q4 2021 | $67,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $67,000 | +3.1% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $65,000 | +27.5% | 500 | +12400.0% | 0.00% | – |
| Q1 2021 | $51,000 | -83.9% | 4 | -78.9% | 0.00% | – |
| Q4 2020 | $316,000 | +310.4% | 19 | +280.0% | 0.00% | – |
| Q3 2020 | $77,000 | -56.5% | 5 | -58.3% | 0.00% | – |
| Q2 2020 | $177,000 | +12.7% | 12 | -14.3% | 0.00% | – |
| Q1 2020 | $157,000 | -93.0% | 14 | -91.3% | 0.00% | -100.0% |
| Q4 2019 | $2,239,000 | +961.1% | 161 | +631.8% | 0.01% | +400.0% |
| Q3 2019 | $211,000 | +1.9% | 22 | +22.2% | 0.00% | 0.0% |
| Q2 2019 | $207,000 | -92.0% | 18 | -91.9% | 0.00% | -85.7% |
| Q1 2019 | $2,601,000 | +700.3% | 221 | +325.0% | 0.01% | +600.0% |
| Q4 2018 | $325,000 | -59.4% | 52 | -54.0% | 0.00% | -66.7% |
| Q3 2018 | $800,000 | +4110.5% | 113 | +3666.7% | 0.00% | – |
| Q2 2018 | $19,000 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 200 | $26,000 | 0.00% |
| SIMPLEX TRADING, LLC | 500 | $65,000 | 0.00% |